Member Info for PM2022

Predictable response. Only because you have no money to buy.

That has been the same pattern since 4D fell.

Agree the company would have been busted without Suzy and Kevin but they made a mess of it with 201 and therefore the share price. Hopefully they can seal the deal with 201 shortly. That will really move the share price big now.

Kevin has stayed to see it through and I suspect Suzy will step down on a high.

She had no choice because otherwise shareholders wanted Kevin gone and then gone after Suzy as well. A combination of experience of shareholders and experience board members is positive.

They have cash until Q2 2025 and with revenue coming in that should be extended. I think 201 will complete so a good cash runway.

You need experience so no choice but to keep him. We have a shareholder on the board and changes as requested.

It is a combination of both experience and shareholder interests which should work. It would have been better had it been Adam before he got turned down.

Was a failure due to delays but not a failure. All to play and will likely complete very soon and the lab will be a success.

EUDA continues its march to the finishing line. News will come shortly.

I guess the matter is settled then. NO EGM which is good. Will those larger buyers promising to buy now buy. I suspect not as it is all cheap talk.

I am sure if new investors were buying here they would be happy with 10p. One can then say they are only about 600% from the highs from 10p.

Not a valid point. EUDA market cap $40 million and rising.

Clearly something is happening soon.

Strong rise on Friday. More like buys than sells.

It shows the value on offer and potential upside from here when 201 completes. We were stable in 40s with a peak at 65p with LOI and no CLX, Imogen or lab so at 3p a steal and still very likely to complete shortly.

I have a low average anyway so it matters now. I was massively in profit now but it matters now.

Expecting merger to complete this month and a strong recovery.

Again you fail to understand the absolute basics and if people were really honest they would know it.

So you talk about 9 evaluations. If these were outsourced to external labs that would be a very significant extra cost compared to bringing them into your own lab times that by 9. Also bringing them internally gives control of timings and allows further testing using some of the agreed collaborations they have therefore giving better chances of positive outcomes.

I don't know as much about Imogen and the biobank business but I doubt you do either but what they are saying is that it will help generate significant revenue soon. The lab alone is not likely to do that. If that is the case then all we can do is wait and see. Valirx is not a lab business just are looking for side revenue and mainly to help progress the evaluation projects.

The only part I would agree with is that they should not spend more on other assets for a long while. Keep spending down until a real deal so that actually means bringing in 3 quality projects a year until they strike a deal. What you don't want is to be funding numerous preclinical projects at the same time at a low share price or without a deal with revenue because then the costs will blow.

You cannot counter my point instead of turning to a post many years back. Weak..

Share price is dictated by market perception of which 0% on this board really understand the strategy fully therefore a false price at the current time.

The only way to fix the issue is to get 201 over the line soon or a deal for CLX or another deal in the next year with cash payments and higher share price plus some decent lab contracts.

No board changes can divert away from that fact and change the situation. It needs experience and knowledge of this industry.

Bloody clueless as it gets.

9 evaluations will cost. So if they pass how will they fund pre clinical testing with zero cash and burning less than 1.5 million.If 3/9 pass you have to fund those. If all 9 fail that will drop the SP and confidence. Based on this they will likely need at least 5 million per year if you bring so many projects in maybe more.

You can only bring in quality products otherwise it is a waste of time and money. The project and terms have to be right some will want more payments to take it on. It takes time to go over the science and negotiate terms for the right projects.

It is all wishful thinking without actually understanding the costs involved. VAL needs 201 to complete for a higher share price and lower dilutions as well as extra money.

Your approach is a bust approach with no understanding of costs, strategy and value adding news.

She could which is why I don't support the requisition at this point as removing Kevin now could lead to Suzy leaving as well.

Those suggested to replace no doubt want Suzy to remain as they need someone that can guild them without any experience in this field but somehow it will not work.

Without all this instability I do think 201 will complete very soon and we will recover at least to double digits with other news coming as well. A completely new BOD just means more mistakes with a lack of experience and the cycle starts again. Rinse and repeat with mistakes after mistakes and an even lower placing.

Why would it as you stated many times that you are not invested.

The Valirx Twitter account is still up so it means nothing

On a positive note EUDA finished up 16% and rumour is that the merger will complete soon.

Euda on the move.

I have feeling this will be the month for sure.

why do you care so much????

with so much projects ongoing including 201, at 5 million market cap it will not take much to take this to 10/15 million comfortably. it would be a right **** up if we are where we are in the coming weeks.

buy low and sell high applies now.

I live on her street next door to you lol.

You would know I suspect.

Performance has been poor but it is all set now, the foundations are in place for lots of news to come. It is a bit like selling a house which is half built, It has no value but when built it is often worth good money. I think we are at the stage where value will now come.

Porky, you have a chance to make money rather than spending your entire life deramping. You can use the profit to invest in a premium membership on Match.com. Think about it.

Assume 201 fails then but personally I think it will get signed as still ongoing. Update on CLX and potential value can move this 200% from here, Lab contracts they seem confident it will come soon, 301 update, 401 should complete. Potential buying at such a low without much news is also a strong chance.

Don't forget outcomes to evaluations as well. If 201 gets signed even a few months later what happens to the SP then.

Nothing is risk free but the odds are good at such a low price. Worth a punt imo.

Worth the risk at the current SP. Any one of at least 5 outcomes can at least double the SP from here before year end.

Easy trade and easy money at this price.